These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21401113)

  • 1. In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides.
    Flaten GE; Kottra G; Stensen W; Isaksen G; Karstad R; Svendsen JS; Daniel H; Svenson J
    J Med Chem; 2011 Apr; 54(7):2422-32. PubMed ID: 21401113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered activity and physicochemical properties of short cationic antimicrobial peptides by incorporation of arginine analogues.
    Svenson J; Karstad R; Flaten GE; Brandsdal BO; Brandl M; Svendsen JS
    Mol Pharm; 2009; 6(3):996-1005. PubMed ID: 19341291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.
    Andersen R; Nielsen CU; Begtrup M; Jørgensen FS; Brodin B; Frokjaer S; Steffansen B
    Eur J Pharm Sci; 2006 Jul; 28(4):325-35. PubMed ID: 16713701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability.
    Svenson J; Vergote V; Karstad R; Burvenich C; Svendsen JS; De Spiegeleer B
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1032-9. PubMed ID: 19952307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of tripeptidic promoieties targeting the intestinal peptide transporter hPEPT1.
    Thorn K; Andersen R; Christensen J; Jakobsen P; Nielsen CU; Steffansen B; Begtrup M
    ChemMedChem; 2007 Apr; 2(4):479-87. PubMed ID: 17407174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
    Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.
    Lequin O; Ladram A; Chabbert L; Bruston F; Convert O; Vanhoye D; Chassaing G; Nicolas P; Amiche M
    Biochemistry; 2006 Jan; 45(2):468-80. PubMed ID: 16401077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
    Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
    ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unnatural amino acid side chains as S1, S1', and S2' probes yield cationic antimicrobial peptides with stability toward chymotryptic degradation.
    Karstad R; Isaksen G; Brandsdal BO; Svendsen JS; Svenson J
    J Med Chem; 2010 Aug; 53(15):5558-66. PubMed ID: 20608742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of antibacterial action of dermaseptin B2: interplay between helix-hinge-helix structure and membrane curvature strain.
    Galanth C; Abbassi F; Lequin O; Ayala-Sanmartin J; Ladram A; Nicolas P; Amiche M
    Biochemistry; 2009 Jan; 48(2):313-27. PubMed ID: 19113844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of human liver-expressed antimicrobial peptide 2.
    Hocquellet A; Odaert B; Cabanne C; Noubhani A; Dieryck W; Joucla G; Le Senechal C; Milenkov M; Chaignepain S; Schmitter JM; Claverol S; Santarelli X; Dufourc EJ; Bonneu M; Garbay B; Costaglioli P
    Peptides; 2010 Jan; 31(1):58-66. PubMed ID: 19852990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the antimicrobial peptide 'window of activity' using cationic lipopeptides with hydrocarbon and fluorinated tails.
    Findlay B; Zhanel GG; Schweizer F
    Int J Antimicrob Agents; 2012 Jul; 40(1):36-42. PubMed ID: 22578748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?
    Papo N; Shai Y
    Peptides; 2003 Nov; 24(11):1693-703. PubMed ID: 15019200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping.
    Pedretti A; De Luca L; Marconi C; Negrisoli G; Aldini G; Vistoli G
    ChemMedChem; 2008 Dec; 3(12):1913-21. PubMed ID: 18979492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disperse distribution of cationic amino acids on hydrophilic surface of helical wheel enhances antimicrobial peptide activity.
    Kim YS; Cha HJ
    Biotechnol Bioeng; 2010 Oct; 107(2):216-23. PubMed ID: 20506191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties.
    Bruschi M; Pirri G; Giuliani A; Nicoletto SF; Baster I; Scorciapino MA; Casu M; Rinaldi AC
    Peptides; 2010 Aug; 31(8):1459-67. PubMed ID: 20438783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1.
    Geissler S; Hellwig M; Zwarg M; Markwardt F; Henle T; Brandsch M
    J Agric Food Chem; 2010 Feb; 58(4):2543-7. PubMed ID: 20104847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides.
    Rosenfeld Y; Lev N; Shai Y
    Biochemistry; 2010 Feb; 49(5):853-61. PubMed ID: 20058937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1.
    Andersen R; Jørgensen FS; Olsen L; Våbenø J; Thorn K; Nielsen CU; Steffansen B
    Pharm Res; 2006 Mar; 23(3):483-92. PubMed ID: 16489544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction.
    Hilpert K; Fjell CD; Cherkasov A
    Methods Mol Biol; 2008; 494():127-59. PubMed ID: 18726572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.